CN101711814B - 一种治疗消化性溃疡的药物及其制备方法与应用 - Google Patents
一种治疗消化性溃疡的药物及其制备方法与应用 Download PDFInfo
- Publication number
- CN101711814B CN101711814B CN 200810198940 CN200810198940A CN101711814B CN 101711814 B CN101711814 B CN 101711814B CN 200810198940 CN200810198940 CN 200810198940 CN 200810198940 A CN200810198940 A CN 200810198940A CN 101711814 B CN101711814 B CN 101711814B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- ulcer
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 61
- 208000008469 Peptic Ulcer Diseases 0.000 title claims abstract description 21
- 208000011906 peptic ulcer disease Diseases 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 19
- 241000756943 Codonopsis Species 0.000 claims abstract description 17
- 230000002496 gastric effect Effects 0.000 claims abstract description 12
- 210000000952 spleen Anatomy 0.000 claims abstract description 12
- 210000002784 stomach Anatomy 0.000 claims abstract description 10
- 208000007107 Stomach Ulcer Diseases 0.000 claims abstract description 6
- 208000000718 duodenal ulcer Diseases 0.000 claims abstract description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 15
- 235000019698 starch Nutrition 0.000 claims description 15
- 239000008107 starch Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 11
- 208000025865 Ulcer Diseases 0.000 claims description 10
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000001694 spray drying Methods 0.000 claims description 10
- 231100000397 ulcer Toxicity 0.000 claims description 10
- 230000001079 digestive effect Effects 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 201000005917 gastric ulcer Diseases 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 230000036407 pain Effects 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 208000032023 Signs and Symptoms Diseases 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000012827 research and development Methods 0.000 description 3
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002467 anti-pepsin effect Effects 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000008991 intestinal motility Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- -1 SIDASHU JIAONANG Chemical compound 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 229940095970 imodium Drugs 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810198940 CN101711814B (zh) | 2008-10-06 | 2008-10-06 | 一种治疗消化性溃疡的药物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810198940 CN101711814B (zh) | 2008-10-06 | 2008-10-06 | 一种治疗消化性溃疡的药物及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101711814A CN101711814A (zh) | 2010-05-26 |
CN101711814B true CN101711814B (zh) | 2013-04-03 |
Family
ID=42416061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810198940 Expired - Fee Related CN101711814B (zh) | 2008-10-06 | 2008-10-06 | 一种治疗消化性溃疡的药物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101711814B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733172A (zh) * | 2005-08-01 | 2006-02-15 | 颜怀玮 | 防治肠炎药食兼用品及制造方法 |
-
2008
- 2008-10-06 CN CN 200810198940 patent/CN101711814B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733172A (zh) * | 2005-08-01 | 2006-02-15 | 颜怀玮 | 防治肠炎药食兼用品及制造方法 |
Non-Patent Citations (1)
Title |
---|
苏启高.胆汁返流性胃炎中医治疗概况.《中医药临床杂志》.2004,第16卷(第1期),6-8. * |
Also Published As
Publication number | Publication date |
---|---|
CN101711814A (zh) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102727686A (zh) | 一种治疗脂肪肝中药组合物 | |
CN104013926A (zh) | 一种中药组合物及其作为脂肪肝治疗药物的应用 | |
CN102397372A (zh) | 一种药物组合物及制剂和其在治疗肠易激综合征中的应用 | |
CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN105535448A (zh) | 一种治疗儿童重症肌无力的中药组合物 | |
CN102293936B (zh) | 一种保护胃粘膜的药物组合物或保健食品组合物及制备方法 | |
CN104383496A (zh) | 一种治疗急慢性肠胃炎的药物 | |
CN102247479B (zh) | 一种抗肿瘤壮药及其制备方法 | |
CN103223069A (zh) | 一种治疗肝炎的中药组合物 | |
CN102228547B (zh) | 一种中药组合物在制备治疗胰腺炎和/或胆囊炎药物中的应用 | |
CN103191167B (zh) | 华泽兰的应用 | |
CN101711814B (zh) | 一种治疗消化性溃疡的药物及其制备方法与应用 | |
CN109674848A (zh) | 一种甘草提取物的制备方法与用途 | |
CN101390970A (zh) | 一种治疗乙肝的中药及其制备方法 | |
CN103550348A (zh) | 一种治疗慢性糜烂性胃炎的中药方剂 | |
CN103735755A (zh) | 一种预防高血压的中药组合物及其制备方法 | |
CN103263658A (zh) | 一种治疗周围性面瘫的中药制剂及其制备方法 | |
CN106668645A (zh) | 一种治疗消化不良的中药配方 | |
CN104784621A (zh) | 一种治疗腹泻的中药组合物及其制备方法和应用 | |
CN104491577B (zh) | 中药制剂用于制备治疗脾胃虚弱型慢性胃炎药物中的用途 | |
CN103705731A (zh) | 一种治疗慢性酒精中毒性肝病的中药组合物 | |
CN103446488A (zh) | 一种保护胃粘膜的药物 | |
CN103830426B (zh) | 一种治疗脉管炎的中药组合物 | |
CN113694167B (zh) | 一种治疗脾胃虚弱型萎缩性胃炎的中药组合物及其制备方法 | |
CN104491811A (zh) | 一种治疗风寒感冒的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: Two 510730 street, Shawan, Luogang District economic and Technological Development Zone, Guangzhou, Guangdong, Qingnian Road Applicant after: Guangdong Zhongda South China Sea Ocean Biotechnology Engineering Center Co.Ltd Address before: Six, building 510330, Haizhu science and technology building, 2429 Xingang East Road, Haizhuqu District, Guangdong, Guangzhou Applicant before: Guangdong Zhongda South China Sea Ocean Biotechnology Engineering Center Co.Ltd |
|
DD01 | Delivery of document by public notice |
Addressee: Wang Rui Document name: Notification of Passing Examination on Formalities |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Guangdong Zhongda South China Sea Ocean Biotechnology Engineering Center Co.Ltd Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20191006 |